Each year, after reviewing high-impact publications and findings from major clinical conferences, my research team and I like to reflect on the key imaging technology trends we've seen across the past year, and forecast how many of these trends will impact the provision of imaging services in the future.
The Next-Generation of Breast Imaging Technologies
Several years ago, women's health vendor Hologic introduced the concept of 3D digital breast tomosynthesis, a new technology thought to revolutionize the breast imaging specialty by increasing the performance of standard 2D digital mammography. Interest from the health care community immediately sparked, with many experts indicating breast tomosynthesis could ultimately supplant digital mammography as the modality of choice for the screening and diagnosis breast cancer in any setting. Despite its promise, the years came and went, but still no tomosynthesis product. The lack of clinical data, a very complicated FDA reviewal process, unclear indications for use, and myriad other factors were, and still are, to blame. Now, it appears one very important and cumbersome barrier to tomosynethsis development is beginning to budge.
Tomosynthesis Inches Closer to Approval with Positive FDA Meeting